Brown Neurosurgery Faculty Dr. Nikos Tapinos “Tinos Therapeutics” Presented at RI Startup Week
As part of Rhode Island Startup Week, business leaders, investors and entrepreneurs convened in Providence to connect with Brown scientists launching breakthrough technologies across health, life sciences and biotechnology, including the Department’s own Dr. Nikos Tapinos who presented Tinos Therapeutics: A new way to target cancer.
“Through cutting-edge research, pioneering scientists, including Nikos Tapinos, an associate professor of neurosurgery and neuroscience at Brown, are now advancing breakthroughs in RNA technology to take on countless other diseases, including cancer, Tapinos said.
‘It’s an inspiring time right now to be focused on RNA therapeutics — this year’s Nobel Prize in Medicine was awarded to the research team that pioneered the RNA modification technology that led to the development of the COVID vaccines,’ Tapinos said. ‘For years, researchers have grown to understand how modifying RNA as a therapeutic will help save patients, and with that knowledge, we now have the COVID vaccine. RNA therapeutics is the next frontier…’
He co-founded Tinos Therapeutics, Inc. in March with pharmaceutical and biotech executive Wendy Perrow, who serves as CEO. The startup’s team is now focused on raising funding to further test the RNA platform’s efficacy through clinical trials and then ultimately FDA approval, which they hope to secure by 2025. By commercializing his scientific discovery, Tapinos is delivering on what he aspired to accomplish as a researcher.
‘For me, the ultimate goal of why I entered science and medicine is to serve people,’ Tapinos said. ‘The only way to serve people is to produce something new, something better that can save lives. The minute that something is discovered in my lab that can save the life of a patient or a child, this, for me, is why we work so hard.'”
Read the whole story Here